Sponsors

IPD Analytics is the pharmaceutical insights platform built for the demands of pharma litigation and patent law. For over two decades, IPD's expert analyst team has tracked each dimension of the drug lifecycle, from patent filing and regulatory approval through generic entry, biosimilar competition, and market loss of exclusivity, covering 4,000+ on-market and in-development drugs across the US and Europe. 

IPD analysts are in the courtroom, attending district court proceedings, IPR and post-grant hearings, EPO oppositions, CJEU and UPC matters, and Federal Circuit appeals, capturing real-time insights on legal arguments, judge reactions, and expert witness performance. That on-the-ground coverage feeds directly into the platform and published reports, so law firms receive intelligence on active matters as it happens. 

Beyond coverage, IPD provides district court, IPR, PGR, settlement, and timing analytics that help firms benchmark PIV outcomes, settlement rates, and litigation timelines at the patent-drug level by jurisdiction, judge, counsel, and manufacturer. For law firms, that means a single platform that sharpens business development, supports active matters, and helps attorneys walk into any case knowing exactly how similar ones have played out.